Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Mir-29 Maintains the Acute Myeloid Leukemia Epigenome By Regulating CBX2

Caryn J. Ha, BA, Wenhuo Hu, PhD, Harold K. Elias, MD, Sohini Chakraborty, PhD, Christopher Y. Park, MD PhD

Blood (2019) 134 (Supplement_1): 1236.

https://doi.org/10.1182/blood-2019-131518

Published: 2019

Journal Articles

Identification of Old HSCs with Preserved Self-Renewal and Long-Term Reconstitution Potential

Harold K. Elias, MD, Joseph Y. Shin, MD PhD, Mohamed A.E. Ali, MD PhD, Sohini Chakraborty, PhD, Caryn J. Ha, BA, Igor Dolgalev, PhD, Colin Konishi, BA, Isabel Beerman, PhD, Christopher Y. Park, MD PhD

Blood (2019) 134 (Supplement_1): 2479.

https://doi.org/10.1182/blood-2019-129508

Published: 2019

Journal Articles

Unique Regulatory Pathways Dictate the Translational Program in Hematopoietic Stem and Progenitor Cells

Harold K. Elias, MD, Christina Spevak, PhD, Lavanya Kannan, PhD, Mohamed A.E. Ali, MD PhD, Gaelle H Martin, PhD, Shanmugapriya Selvaraj, MS, William S Eng, Guangjie Zhao, BS, Amanda Ernlund, PhD, Vinagolu Rajasekhar, PhD, Carolien M Woolthuis, MD PhD, Robert J Schneider, PhD, Christopher Y. Park, MD PhD

Blood (2019) 134 (Supplement_1): 1180.

https://doi.org/10.1182/blood-2019-131333

Published: 2019

Journal Articles

Mtor-Independent Translation in Early Hematopoietic Development

Christina Spevak, PhD, Harold Elias, MD, Lavanya Kannan, PhD, Gaelle Martin, PhD, Shanmugapriya Selvaraj, William Eng, Amanda Ernlund, Vinagolu Rajasekhar, PhD, Carolien Woolthuis, MD PhD, Robert Schneider, PhD, Christopher Y. Park, MD PhD

Blood (2018) 132 (Supplement 1): 3827.

https://doi.org/10.1182/blood-2018-99-120191

Published: 2018

Journal Articles

CD99 Regulates Normal and Malignant Stem Cell Function By Restricting Protein Translation

Stephen S. Chung, MD, Wenhuo Hu, PhD, Liang Guo, PhD, Lavanya Kannan, PhD, Ross L. Levine, MD, Christopher Y. Park, MD PhD

Blood (2017) 130 (Supplement 1): 3749.

https://doi.org/10.1182/blood.V130.Suppl_1.3749.3749

Published: 2017

Journal Articles

Hypermethylation of GADD45A Defines a Methylation Profile Distinct to Mutant IDH1/2 , and Correlates with More Aggressive AML

Blood (2016) 128 (22): 2877.

https://doi.org/10.1182/blood.V128.22.2877.2877

Published: 2016

Journal Articles

Mir-99 Regulates Normal and Leukemic Stem Cell Function

Mona Khalaj, PhDcandidate, Carolien Woolthuis, PhD, Wenhuo Hu, PhD, Benjamin Heath Durham, MD BS, Christopher Y. Park, MD PhD

Blood (2016) 128 (22): 1469.

https://doi.org/10.1182/blood.V128.22.1469.1469

Published: 2016

Journal Articles

Changes of the Mutational Landscape in Relapsed Acute Myeloid Leukemia

Blood (2016) 128 (22): 599.

https://doi.org/10.1182/blood.V128.22.599.599

Published: 2016

Journal Articles

CD97 Is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function

Gaëlle H Martin, PhD, Alexis Desrichard, PhD, Stephen S. Chung, MD, Carolien Woolthuis, PhD, Wenhuo Hu, PhD, Francine E. Garrett-Bakelman, MD PhD, Jörg Hamann, PhD, Timothy Chan, MD PhD, Christopher Y. Park, MD PhD

Blood (2016) 128 (22): 1077.

https://doi.org/10.1182/blood.V128.22.1077.1077

Published: 2016

Journal Articles

An Analysis of the Transcriptional Response of Myelodysplastic Syndrome Stem Cells to Therapy at Single Cell Resolution

Stephen S. Chung, MD, Priyanka Vijay, Diana L. Stern, Virginia M. Klimek, MD, Christopher E. Mason, PhD, Christopher Y. Park, MD PhD

Blood (2016) 128 (22): 960.

https://doi.org/10.1182/blood.V128.22.960.960

Published: 2016

Journal Articles

Frequent Clinical Overlap of Histiocytic Neoplasms and WHO-Classified Myeloid Malignancies Leads to Functional Insights into the Cell-of-Origin of Histiocytoses

Benjamin Heath Durham, MD BS, Akihide Yoshimi, MD PhD, Matthias Papo, Young Rock Chung, MS, Neval Ozkaya, MD, Chezi Ganzel, Ahmet Dogan, David M. Hyman, Christopher Y. Park, MD PhD, Raajit K. Rampal, MD, PhD, Damien Roos Weil, Francois Michel Lemoine, MD PhD, Zahir Amoura, Olivier A. Bernard, PhD, Eli L. Diamond, MD, Jean-François Emile, MD PhD, Julien Haroche, MD PhD, Omar Abdel-Wahab, MD

Blood (2016) 128 (22): 951.

https://doi.org/10.1182/blood.V128.22.951.951

Published: 2016

Journal Articles

Desuppressed Expressionsof MiR-29 targetsdisturb the Leukemeugenesis of MLL-AF9

Wenhuo Hu, PhD, Christopher Y. Park, MD, PhD

Blood (2015) 126 (23): 1228.

https://doi.org/10.1182/blood.V126.23.1228.1228

Published: 2015

Journal Articles

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

Benjamin Heath Durham, MD BS, Eli L. Diamond, MD, Julien Haroche, MD PhD, Zhan Yao, PhD, Jing Ma, PhD, Sameer A. Parikh, MD, John Choi, Eunhee Kim, PhD, Fleur Cohen-Aubart, Stanley Chun-Wei Lee, Yijun Gao, Jean-Baptiste Micol, MD, Patrick Campbell, MD PhD, Michael P. Walsh, Brooke Sylvester, Igor Dolgalev, Aminova Olga, Adriana Heguy, Paul Zappile, Joy Nakitandwe, BSc,MSc,PhD, James Dalton, BS, David W Ellison, MD, Juvianee Estrada-Veras, Mario Lacouture, William A. Gahl, MD PhD, Phil Stephens, PhD, Vincent A. Miller, MD, Jeffrey Ross, Siraj Ali, Sebastien Héritier, Jean Donadieu, MD PhD, David Solit, MD, David M. Hyman, Jose Baselga, MD PhD, Filip Janku, MDPhD, Barry S. Taylor, PhD, Christopher Y. Park, MD, PhD, Ahmet Dogan, MD PhD, Zahir Amoura, Jean-Francois Emile, Raajit K. Rampal, MD, PhD, Neal Rosen, MD PhD, Tanja A. Gruber, MD PhD, Omar Abdel-Wahab

Blood (2015) 126 (23): 481.

https://doi.org/10.1182/blood.V126.23.481.481

Published: 2015

Journal Articles

Targeting CD99 in T-Cell Neoplasms with Monoclonal Antibodies

Montreh Tavakkoli, MA, Dong H. Lee, MD, Benjamin Durham, MD PhD, Stephen S. Chung, MD, Christopher Y. Park, MD, PhD

Blood (2015) 126 (23): 2749.

https://doi.org/10.1182/blood.V126.23.2749.2749

Published: 2015

Journal Articles

Rejuvenation of Aged Vascular Niches to Enhance Hematopoietic Function

Michael Gustave Poulos, PhD, Michael Gutkin, M.S., Christopher Y. Park, MD, PhD, Jason M. Butler, PhD

Blood (2015) 126 (23): 781.

https://doi.org/10.1182/blood.V126.23.781.781

Published: 2015

Journal Articles

Analysis of Myelodysplastic Syndrome Stem Cells at Single Cell Resolution during DNA Methyltransferase Inhibitor Therapy

Stephen S. Chung, MD, Priyanka Vijay, Diana L. Stern, Deirdre O'Sullivan, Virginia M. Klimek, MD, Christopher Mason, PhD, Christopher Y. Park, MD, PhD

Blood (2015) 126 (23): 4101.

https://doi.org/10.1182/blood.V126.23.4101.4101

Published: 2015

Journal Articles

Divergent Dynamics of Epigenetic and Genetic Heterogeneity in Relapsed Acute Myeloid Leukemia

Blood (2015) 126 (23): 306.

https://doi.org/10.1182/blood.V126.23.306.306

Published: 2015

Journal Articles

Mir-99 Is a Regulator of Hematopoietic and Leukemic Stem Cell Differentiation

Mona Khalaj, PhDcandidate, Wenhuo Hu, PhD, Christopher Y. Park, MD, PhD

Blood (2015) 126 (23): 3063.

https://doi.org/10.1182/blood.V126.23.3063.3063

Published: 2015

Journal Articles

Mutation Profiling of Therapy-Related Myeloid Neoplasms Using Next-Generation Sequencing Demonstrates Distinct Profiles from De Novo Disease

Alan H. Shih, MDPhD, Franck Rapaport, PhD, Stephen S. Chung, MD, Emily K Dolezal, Sean Hobson, MA, Mary K Amato, Christopher Y. Park, MD PhD, Mikkael A. Sekeres, MD MS, Marcel R.M. van den Brink, MD PhD, Stephen Nimer, MD, Ross L. Levine, MD, Jaroslaw P. Maciejewski, MD PhD, Virginia M. Klimek, MD

Blood (2014) 124 (21): 4611.

https://doi.org/10.1182/blood.V124.21.4611.4611

Published: 2014

Journal Articles

MiR-29a is Essential in Leukemic Transformation and Maintaining Hematopoietic Stem Cell Self-Renewal

Wenhuo Hu, PhD, James Dooley, PhD, Luisa Cimmino, PhD, Adrian Liston, PhD, Christopher Y. Park, MD PhD

Blood (2014) 124 (21): 4792.

https://doi.org/10.1182/blood.V124.21.4792.4792

Published: 2014

NARROW

Mir-29 Maintains the Acute Myeloid Leukemia Epigenome By Regulating CBX2

Identification of Old HSCs with Preserved Self-Renewal and Long-Term Reconstitution Potential

Unique Regulatory Pathways Dictate the Translational Program in Hematopoietic Stem and Progenitor Cells

Mtor-Independent Translation in Early Hematopoietic Development

CD99 Regulates Normal and Malignant Stem Cell Function By Restricting Protein Translation

Hypermethylation of GADD45A Defines a Methylation Profile Distinct to Mutant IDH1/2 , and Correlates with More Aggressive AML

Mir-99 Regulates Normal and Leukemic Stem Cell Function

Changes of the Mutational Landscape in Relapsed Acute Myeloid Leukemia

CD97 Is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function

An Analysis of the Transcriptional Response of Myelodysplastic Syndrome Stem Cells to Therapy at Single Cell Resolution

Frequent Clinical Overlap of Histiocytic Neoplasms and WHO-Classified Myeloid Malignancies Leads to Functional Insights into the Cell-of-Origin of Histiocytoses

Desuppressed Expressionsof MiR-29 targetsdisturb the Leukemeugenesis of MLL-AF9

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

Targeting CD99 in T-Cell Neoplasms with Monoclonal Antibodies

Rejuvenation of Aged Vascular Niches to Enhance Hematopoietic Function

Analysis of Myelodysplastic Syndrome Stem Cells at Single Cell Resolution during DNA Methyltransferase Inhibitor Therapy

Divergent Dynamics of Epigenetic and Genetic Heterogeneity in Relapsed Acute Myeloid Leukemia

Mir-99 Is a Regulator of Hematopoietic and Leukemic Stem Cell Differentiation

Mutation Profiling of Therapy-Related Myeloid Neoplasms Using Next-Generation Sequencing Demonstrates Distinct Profiles from De Novo Disease

MiR-29a is Essential in Leukemic Transformation and Maintaining Hematopoietic Stem Cell Self-Renewal

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only